
通过观察脐血单个核细胞联合髓芯减压植骨的治疗效果,为临床早期股骨头坏死的治疗提供参考。
对本科室2019年7月至2019年12月接收的早期股骨头坏死40例患髋,按照随机分配的原则将其分为两组,脐血单个核细胞联合髓芯减压植骨为治疗组,单纯髓心减压植骨术为对照组。通过观察患者Harris评分、VAS评分、股骨头X线整体稳定率、股骨头塌陷程度、MRI囊性变面积变化情况,评估脐血单个核细胞联合髓芯减压植骨治疗效果。
患者治疗组Harris评分、VAS评分情况均优于对照组,差异具有统计学意义(P < 0.05),股骨头X线整体稳定率良好、未见股骨头塌陷,MRI囊性变面积与对照组相比,差异均具有统计学意义(P < 0.05)。
脐血单个核细胞联合髓芯减压植骨治疗早期股骨头坏死的效果较为显著,为临床应用提供了一种更为有效的治疗方法。
1 | 曾祥洪, 梁博伟. 股骨头坏死保髋治疗的新策略 [J]. 中国组织工程研究,2021,25(3):431. |
2 | Sultan AA, Khlopas A, Surace P, et al. The use of non-vascularized bone grafts to treat osteonecrosis of the femoral head: Indications, techniques, and outcomes [J]. Int Orthop, 2019, 43(6):1315. |
3 | 杨澜波, 黄涛, 王财儒,等.靶向减压填充β-TCP治疗股骨头坏死 [J]. 中国矫形外科杂志, 2020, 28(3):225. |
4 | Li B, Lei P, Liu H, et al. Clinical value of 3D printing guide plate in core decompression plus porous bioceramics rod placement for the treatment of early osteonecrosis of the femoral head [J]. Orthop Surg Res, 2018, 13(1):130. |
5 | Lu Y, Lu X, Li M, et al. Minimally invasive treatment for osteonecrosis of the femoral head with angioconductive bioceramic rod [J]. Int Orthop, 2018, 42(7):1567. |
6 | 王利, 张超, 刘承军, 等. 脐血移植在血液系统疾病中的临床应用研究进展 [J]. 中国实验血液学杂志, 2020, 28(3):1049. |
7 | Peng X, Song J, Li B, et al. Umbilical cord blood stem cell therapy in premature brain injury: Opportunities and challenges [J]. Neurosci Res, 2020, 98(5):815. |
8 | 张梦云, 李茹, 娄满, 等. 人脐血单个核细胞经椎管途径移植治疗血管性痴呆的临床研究 [J]. 脑与神经疾病杂志,2020, 28(12):768. |
9 | 邱晨, 彭昊, 彭普基, 等. 人脐带间充质干细胞防治早期激素性股骨头坏死的作用及其机制 [J]. 中华实验外科杂志, 2021, 38(2):309. |
10 | Sica RA, Terzioglu MK, Mahmud D, et al. Mechanistic basis of ex vivo umbilical cord blood stem progenitor cell expansion [J]. Stem Cell Rev Rep, 2020, 16(4):628. |
11 | 鲁亚杰, 王臻, 卢霄, 等. 生物陶瓷系统微创治疗ARCOⅡ、Ⅲ期股骨头坏死 [J]. 中国修复重建外科杂志, 2019, 33(10):1291. |
12 | Li B, Hu R, Sun L, et al. A CARE-compliant article: Biomechanics of treating early-stage femoral-head osteonecrosis by using a beta-tricalcium phosphate bioceramic rod system: A 3-dimensional finite-element analysis [J]. Medicine (Baltimore),2018, 97(25). |
13 | 黄娜, 刘家玥, 黄英杰, 等. Web of Science数据库近5年股骨头坏死文献计量学及可视化分析 [J]. 中国组织工程研究, 2021, 25(17):2711. |
14 | Song JS, Hong KT, Kim NM, et al. Human umbilical cord blood-derived mesenchymal stem cell implantation for osteoarthritis of the knee. [J]. Arch Orthop Trauma Surg, 2020, 140(4):503. |
15 | 王未飞, 于海燕, 袁晓玲, 等. 脐血单个核细胞移植对帕金森病的临床疗效研究 [J]. 中华细胞与干细胞杂志(电子版), 2020, 10(6):341. |
16 | Tahlawi A, Klontzas ME, Allenby MC, et al. RGD-functionalized polyurethane scaffolds promote umbilical cord blood mesenchymal stem cell expansion and osteogenic differentiation. [J]. Tissue Eng Regen Med, 2019, 13(2):232. |
To observe the therapeutic effect of umbilical cord blood mononuclear cells combined with marrow core decompression and bone grafting, and to provide a reference for the treatment of femoral head necrosis in early clinical stage.
Forty patients with early femoral head necrosis received from July 2019 to December 2019 in this department were divided into two groups according to the principle of random distribution. By observing patients' Harris score, VAS score, overall stability of femoral head X-ray, degree of femoral head collapse, and changes of MRI cystic variable area, the effect of umbilical cord blood mononuclear cells combined with core decompression and bone grafting was evaluated.
the Harris score and VAS score in the treatment group were better than those in the control group (P < 0.05), the difference was statistically significant, the overall stability of femoral head X-ray was good, no femoral head collapse was observed, and the difference in MRI cystic change area was statistically significant compared with the control group (P < 0.05).
mononuclear cells of umbilical cord blood combined with core decompression and bone grafting are effective in the treatment of early femoral head necrosis, which provides a more effective treatment for clinical application.
脐血单个核细胞联合髓芯减压植骨治疗早期股骨头坏死的临床效果
李军, 魏开斌, 常辉, 王强, 初培罡, 张文正, 卓锋, 杨伟娟
betway必威登陆网址 (betway.com )学报››2021, Vol. 42››Issue (10): 744-747.
脐血单个核细胞联合髓芯减压植骨治疗早期股骨头坏死的临床效果
The clinical effect of umbilical cord blood mononuclear cells combined with marrow core decompression and bone grafting in the treatment of early femoral head necrosis
通过观察脐血单个核细胞联合髓芯减压植骨的治疗效果,为临床早期股骨头坏死的治疗提供参考。
对本科室2019年7月至2019年12月接收的早期股骨头坏死40例患髋,按照随机分配的原则将其分为两组,脐血单个核细胞联合髓芯减压植骨为治疗组,单纯髓心减压植骨术为对照组。通过观察患者Harris评分、VAS评分、股骨头X线整体稳定率、股骨头塌陷程度、MRI囊性变面积变化情况,评估脐血单个核细胞联合髓芯减压植骨治疗效果。
患者治疗组Harris评分、VAS评分情况均优于对照组,差异具有统计学意义(P< 0.05),股骨头X线整体稳定率良好、未见股骨头塌陷,MRI囊性变面积与对照组相比,差异均具有统计学意义(P< 0.05)。
脐血单个核细胞联合髓芯减压植骨治疗早期股骨头坏死的效果较为显著,为临床应用提供了一种更为有效的治疗方法。
To observe the therapeutic effect of umbilical cord blood mononuclear cells combined with marrow core decompression and bone grafting, and to provide a reference for the treatment of femoral head necrosis in early clinical stage.
Forty patients with early femoral head necrosis received from July 2019 to December 2019 in this department were divided into two groups according to the principle of random distribution. By observing patients' Harris score, VAS score, overall stability of femoral head X-ray, degree of femoral head collapse, and changes of MRI cystic variable area, the effect of umbilical cord blood mononuclear cells combined with core decompression and bone grafting was evaluated.
the Harris score and VAS score in the treatment group were better than those in the control group (P< 0.05), the difference was statistically significant, the overall stability of femoral head X-ray was good, no femoral head collapse was observed, and the difference in MRI cystic change area was statistically significant compared with the control group (P< 0.05).
mononuclear cells of umbilical cord blood combined with core decompression and bone grafting are effective in the treatment of early femoral head necrosis, which provides a more effective treatment for clinical application.
femoral head necrosis/umbilical cord blood mononuclear cells/core decompression/bone graft
1 | 曾祥洪, 梁博伟. 股骨头坏死保髋治疗的新策略 [J]. 中国组织工程研究,2021,25(3):431. |
2 | Sultan AA, Khlopas A, Surace P, et al. The use of non-vascularized bone grafts to treat osteonecrosis of the femoral head: Indications, techniques, and outcomes [J]. Int Orthop, 2019, 43(6):1315. |
3 | 杨澜波, 黄涛, 王财儒,等.靶向减压填充β-TCP治疗股骨头坏死 [J]. 中国矫形外科杂志, 2020, 28(3):225. |
4 | Li B, Lei P, Liu H, et al. Clinical value of 3D printing guide plate in core decompression plus porous bioceramics rod placement for the treatment of early osteonecrosis of the femoral head [J]. Orthop Surg Res, 2018, 13(1):130. |
5 | Lu Y, Lu X, Li M, et al. Minimally invasive treatment for osteonecrosis of the femoral head with angioconductive bioceramic rod [J]. Int Orthop, 2018, 42(7):1567. |
6 | 王利, 张超, 刘承军, 等. 脐血移植在血液系统疾病中的临床应用研究进展 [J]. 中国实验血液学杂志, 2020, 28(3):1049. |
7 | Peng X, Song J, Li B, et al. Umbilical cord blood stem cell therapy in premature brain injury: Opportunities and challenges [J]. Neurosci Res, 2020, 98(5):815. |
8 | 张梦云, 李茹, 娄满, 等. 人脐血单个核细胞经椎管途径移植治疗血管性痴呆的临床研究 [J]. 脑与神经疾病杂志,2020, 28(12):768. |
9 | 邱晨, 彭昊, 彭普基, 等. 人脐带间充质干细胞防治早期激素性股骨头坏死的作用及其机制 [J]. 中华实验外科杂志, 2021, 38(2):309. |
10 | Sica RA, Terzioglu MK, Mahmud D, et al. Mechanistic basis of ex vivo umbilical cord blood stem progenitor cell expansion [J]. Stem Cell Rev Rep, 2020, 16(4):628. |
11 | 鲁亚杰, 王臻, 卢霄, 等. 生物陶瓷系统微创治疗ARCOⅡ、Ⅲ期股骨头坏死 [J]. 中国修复重建外科杂志, 2019, 33(10):1291. |
12 | Li B, Hu R, Sun L, et al. A CARE-compliant article: Biomechanics of treating early-stage femoral-head osteonecrosis by using a beta-tricalcium phosphate bioceramic rod system: A 3-dimensional finite-element analysis [J]. Medicine (Baltimore),2018, 97(25). |
13 | 黄娜, 刘家玥, 黄英杰, 等. Web of Science数据库近5年股骨头坏死文献计量学及可视化分析 [J]. 中国组织工程研究, 2021, 25(17):2711. |
14 | Song JS, Hong KT, Kim NM, et al. Human umbilical cord blood-derived mesenchymal stem cell implantation for osteoarthritis of the knee. [J]. Arch Orthop Trauma Surg, 2020, 140(4):503. |
15 | 王未飞, 于海燕, 袁晓玲, 等. 脐血单个核细胞移植对帕金森病的临床疗效研究 [J]. 中华细胞与干细胞杂志(电子版), 2020, 10(6):341. |
16 | Tahlawi A, Klontzas ME, Allenby MC, et al. RGD-functionalized polyurethane scaffolds promote umbilical cord blood mesenchymal stem cell expansion and osteogenic differentiation. [J]. Tissue Eng Regen Med, 2019, 13(2):232. |
/
〈 | 〉 |